000			02048 a2200565 4500
005			20250515110110.0
264		0	_c20080509
008			200805s 0 0 eng d
022			_a0002-9440
024	7		_a10.2353/ajpath.2008.070601 _2doi
040			_aNLM _beng _cNLM
100	1		_aNinichuk, Volha
245	0	0	_aLate onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. _h[electronic resource]
260			_bThe American journal of pathology _cMar 2008
300			_a628-37 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAptamers, Nucleotide _xtherapeutic use
650	0	4	_aCell Count
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aChemokine CCL2 _xantagonists & inhibitors
650	0	4	_aDiabetes Mellitus, Type 1 _xcomplications
650	0	4	_aDiabetic Nephropathies _xprevention & control
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aKidney _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred NOD
650	0	4	_aNephrectomy
650	0	4	_aNephritis, Interstitial _xetiology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReceptors, CCR2 _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTransforming Growth Factor beta _xmetabolism
700	1		_aClauss, Sebastian
700	1		_aKulkarni, Onkar
700	1		_aSchmid, Holger
700	1		_aSegerer, Stephan
700	1		_aRadomska, Ewa
700	1		_aEulberg, Dirk
700	1		_aBuchner, Klaus
700	1		_aSelve, Norma
700	1		_aKlussmann, Sven
700	1		_aAnders, Hans-Joachim
773	0		_tThe American journal of pathology _gvol. 172 _gno. 3 _gp. 628-37
856	4	0	_uhttps://doi.org/10.2353/ajpath.2008.070601 _zAvailable from publisher's website
999			_c17764345 _d17764345